respiratory
Cystic fibrosis

Another step along the path of translational gene therapy


A proof of concept trial has shown that non-viral gene therapy can stabilise FEV1 in cystic fibrosis patients. The results provide “another step along the path” of translational cystic fibrosis gene therapy and should encourage the rapid introduction of more potent gene transfer vectors into early phase trials, wrote the authors in the paper published ...

Already a member?

Enter your email to keep reading.


OR